Editorial overview: Gastrointestinal regulatory peptides

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 17, Issue 1, 2010, Pages 31-32

  Weber, H Christian ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GASTRIN; GASTROINTESTINAL POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; PROTON PUMP INHIBITOR; SOMATOSTATIN;

ACHLORHYDRIA; EDITORIAL; GASTROINTESTINAL TRACT; HIP FRACTURE; HUMAN; INTESTINE INFECTION; OSSIFICATION; PEPTIDE SYNTHESIS; STOMACH ACID SECRETION;

GASTROINTESTINAL HORMONES; GASTROINTESTINAL TRACT; HUMANS; SIGNAL TRANSDUCTION;

EID: 75149119751     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e328335366a     Document Type: Editorial

References (18)

1. Bayliss WM, Starling EH. The mechanism of pancreatic secretion. J Physiol 1902; 28:325-353.
2. Edkins J. On the chemical mechanism of gastric acid secretion. Proc R Soc Lond B Biol Sci 1905; 76:376-390.
3. Edkins JS. The chemical mechanism of gastric secretion. J Physiol 1906; 34:133-144.
4. Engelstoft MS, Egerod KL, Holst B, Schwartz TW. A gut feeling for obesity: 7TM sensors on enteroendocrine cells. Cell Metab 2008; 8:447-449.
5. Woods SC. The control of food intake: behavioral versus molecular perspectives. Cell Metab 2009; 9:489-498.
6. Yadav VK, Ryu JH, Suda N, et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 2008; 135:825-837.
7. Cheung GW, Kokorovic A, Lam CK, et al. Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab 2009; 10:99-109.
8. Long F. When the gut talks to bone. Cell 2008; 135:795-796.
9. Boyce BF. Stomaching calcium for bone health. Nat Med 2009; 15:610-612.
10. Schinke T, Schilling AF, Baranowsky A, et al. Impaired gastric acidification negatively affects calcium homeostasis and bone mass. Nat Med 2009; 15:674-681.
11. Ferron M, Karsenty G. The gutsy side of bone. Cell Metab 2009; 10: 7-8.
12. Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ 2008; 336:2-3.
13. Insogna KL. The effect of proton pump-inhibiting drugs on mineral metabolism. Am J Gastroenterol 2009; 104 (Suppl 2):S2-S4.
14. Laine L. Proton pump inhibitors and bone fractures? Am J Gastroenterol 2009; 104 (Suppl 2):S21-S26.
15. Metz DC. Clostridium difficile colitis: wash your hands before stopping the proton pump inhibitor. Am J Gastroenterol 2008; 103:2314-2316.
16. Cunningham R. Proton pump inhibitors and the risk of Clostridium difficileassociated disease: further evidence from the community. CMAJ 2006; 175:757-758.
17. de Visser M, Verwijnen SM, de Jong M. Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy. Cancer Biother Radiopharm 2008; 23:137-157.
18. Khan IU, Beck-Sickinger AG. Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals. Anticancer Agents Med Chem 2008; 8:186-199.